Another possible mechanism of resistance to STI571

被引:6
|
作者
Knight, ZA [1 ]
机构
[1] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA
关键词
D O I
10.1182/blood.V96.12.4003.h8004000d_4003_4005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:4003 / 4004
页数:2
相关论文
共 50 条
  • [31] Resistance to daunorubicin-induced apoptosis is not completely reversed in CML blast cells by STI571
    Tabrizi, R
    Mahon, FX
    Makhoul, PC
    Lagarde, V
    Lacombe, F
    Berthaud, P
    Melo, JV
    Reiffers, J
    Belloc, F
    [J]. LEUKEMIA, 2002, 16 (06) : 1154 - 1159
  • [32] Molecular and chromosomal mechanisms of resistance in CML patients after STI571 (Glivec) therapy.
    Kreil, S
    Müller, MC
    Lahaye, T
    La Rosée, P
    Corbin, AS
    Schoch, C
    Cross, NCP
    Berger, U
    Rieder, H
    Druker, BJ
    Gschaidmeier, H
    Hehlmann, R
    Hochhaus, A
    [J]. BLOOD, 2001, 98 (11) : 435A - 435A
  • [33] The rationale engineering of BCR/ABL blockers: an answer to STI571 acquired resistance in leukemia treatment
    Majsterek, IJ
    [J]. LEUKEMIA RESEARCH, 2005, 29 (06) : 605 - 606
  • [34] Resistance to daunorubicin-induced apoptosis is not completely reversed in CML blast cells by STI571
    R Tabrizi
    FX Mahon
    P Cony Makhoul
    V Lagarde
    F Lacombe
    P Berthaud
    JV Melo
    J Reiffers
    F Belloc
    [J]. Leukemia, 2002, 16 : 1154 - 1159
  • [35] Mechanisms of resistance to STI571 (Imatinib) in Philadelphia-chromosome positive acute lymphoblastic leukemia
    Hofmann, WK
    Komor, M
    Hoelzer, D
    Ottmann, OG
    [J]. LEUKEMIA & LYMPHOMA, 2004, 45 (04) : 655 - 660
  • [36] STI571, a molecularly targeted treatment modality for CML.
    Buchdunger, E
    Peng, B
    Ford, J
    Capdeville, R
    Resta, D
    Druker, B
    Sawyers, C
    Talpaz, M
    [J]. CLINICAL CANCER RESEARCH, 2000, 6 : 4482S - 4482S
  • [37] Effects of STI571 (gleevec) on pancreatic cancer cell growth
    Junsheng Li
    Jörg Kleeff
    Junchao Guo
    Lars Fischer
    Nathalia Giese
    Markus W Büchler
    Helmut Friess
    [J]. Molecular Cancer, 2 (1)
  • [38] STI571的研究进展及启示
    田红
    [J]. 国际输血及血液学杂志, 2001, (04) : 304 - 306
  • [39] Efficacy of STI571 for a patient with metastatic gastrointestinal stromal tumor
    Sasaki, Y
    Niwa, Y
    Ando, N
    Otsuka, Y
    Ohmiya, N
    Hirooka, Y
    Itoh, A
    Furuta, S
    Goto, H
    [J]. HEPATO-GASTROENTEROLOGY, 2005, 52 (66) : 1764 - 1767
  • [40] Synergistic activity of STI571 with chemotherapeutic drugs and irradiation.
    Topaly, J
    Zeller, WJ
    Fruehauf, S
    [J]. BLOOD, 2000, 96 (11) : 736A - 736A